THE ROLE OF ANTICHOLINERGIC PROPERTIES OF DRUGS IN THE DEVELOPMENT OF FALLS IN PATIENTS OF SENILE AGE


Cite item

Full Text

Abstract

The article presents own results of the effect of anticholinergic properties of drugs on the development of falls in senile cardiovascular disease (CVD) patients under conditions of polypharmacy. The total anticholinergic load was calculated according to the ACBS scale (Anticholinergic Cognitive Burden Scale). Our study showed the ACB scale to be convenient and allows us to identify designations of dangerous drugs that can disrupt cognitive abilities in CVD patients of older age groups, leading to a fall.

About the authors

Ekaterina S. Ilina

Russian Medical Academy of Continuous Professional Education

Email: katelina@mail.ru
MD, Lecturer of the Department of Clinical Pharmacology and Therapy, Moscow, 125993, Russian Federation Moscow, 125993, Russian Federation

S. P Bordovsky

I.M. Sechenov First Moscow State Medical University

Moscow, 119435, Russian Federation

N. I Polshina

I.M. Sechenov First Moscow State Medical University

Moscow, 119435, Russian Federation

V. E Nikulin

I.M. Sechenov First Moscow State Medical University

Moscow, 119435, Russian Federation

S. V Gorbotenkova

Hospital for veterans of wars № 2

Moscow, 109472, Russian Federation

O. T Bogova

Russian Medical Academy of Continuous Professional Education

Moscow, 125993, Russian Federation

T. A Ivanova

Diagnostic Сenter № 3 of the Department of Health of Moscow City

Moscow, 109444, Russian Federation

I. V Lyalina

Main Clinical Centre of Medical and Social Rehabilitation of the Federal Service of Execution of Punishments

Moscow, 109428, Russian Federation

D. A Sychev

Russian Medical Academy of Continuous Professional Education

Moscow, 125993, Russian Federation

References

  1. Падения. Информационный бюллетень ВОЗ. Август 2017 г. http://www.who.int/mediacentre/factsheets/fs344/ru/
  2. Baranzini F., Diurni M., Ceccon F., Poloni N., Cazzamalli S., Costantini C. et al. Fall-related injuries in a nursing home setting: Is polypharmacy a risk factor? BMC Health Services Res. 2009;9: 228.
  3. National Institute for Health and Care Excellence (NICE). Falls in older people. http://pathways.nice.org.uk/pathways/falls-in-older-people
  4. WHO Global Report on Falls Prevention in Older Age. Community Health.2007. http://www.who.int/ageing/publications/Falls_prevention7March.pdf.
  5. Coutinho Ed Eda S., Silva S.D. Medication as a risk factor for falls resulting in severe fractures in the elderly. Cad. Saude Publica. 2002; 18: 1359-66.
  6. Cumming R.G., Klineberg R.J. Psychotropics, thiazide diuretics and hip fractures in the elderly. Med. J. 1993; 158: 414-17.
  7. Monane M., Avorn J. Medications and falls: causation, correlation, and prevention. Clin. Geriatr. Med. 1996; 12: 847-58.
  8. Leipzig R.M., Cumming R.G., Tinetti M.E. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J. Am. Geriatr. Soc.1999; 47: 30-9.
  9. Leipzig R.M., Cumming R.G., Tinetti M.E. Drugs and Falls in Older People: a Systematic Review and Meta-Analysis: II. Cardiac and Analgesic Drugs. JAGS. 1999; 47: 40-50.
  10. Tinetti M.E., Han L., Lee D.S.H. et al. Antihyprttensive medications and serious injuriesin a national representative sample of older adults. JAMA Intern. Med. 2014; 174 (4): 588-95.
  11. Woolcott J.C., Richardson K.J., Wiens M.O. et all. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch. Intern. Med. 2009, 169: 1952-60. 10.1001/archinternmed.2009.357.
  12. Carnahan R.M., Lund B.C., Perry P.J., Pollock B.G., Culp K.R. The Anticholinergic Drug Scale as measure of drug related anticholinergic burden: association with serum anticholinergic activity. J. Clin. Pharmacol. 2006; 46: 1481-6.
  13. Salahudeen M.S., Duffull S.B., Nishtala P.S. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015; 15: 31.
  14. Carrière I., Fourrier-Reglat A., Dartigues J.-F. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch. Intern. Med. 2009; 169 (14): 1317-24. doi: 10.1001/archinternmed.2009.229
  15. http://www.agingbraincare.org/tools/abc-anticholinergic-cognitive-burden-scale
  16. Fox C., Richardson K., Maidment I. et al. Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council Function and Ageing Study. J. Am. Geriatr. Soc. 2011; 59(8): 1477-83.
  17. Richardson K., Bennett K., Maidment I.D. et al. Use of Medications with Anticholinergic Activity and Self-Reported Injurious Falls in Older Community-Dwelling Adults. J. Am. Geriatr. Soc. 2015; 63(8): 1561-9.
  18. Назаренко Г.И., Клейменова Е.Б., Отделенов В.А. и др. Использование триггеров нежелательных событий для выявления побочных реакций при применении лекарственных средств в стационаре. Клиническая фармакология и терапия. 2015. 24 (4): 55-62.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Eco-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).